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Identification of Nicotinic Acetylcholine Receptor Recycling and Its Role
inn Maintaining Receptor Density at the Neuromuscular Junction In Vivo
Abstract
In the CNS, receptor recycling is critical for synaptic plasticity; however, the recycling of receptors has never
been observed at peripheral synapses. Using a novel imaging technique, we show here that nicotinic
acetylcholine receptors (AChRs) recycle into the postsynaptic membrane of the neuromuscular junction. By
sequentially labeling AChRs with biotin-bungarotoxin and streptavidin-fluorophore conjugates, we were able
to distinguish recycled, preexisting, and new receptor pools at synapses in living mice. Time-lapse imaging
revealed that recycled AChRs were incorporated into the synapse within hours of initial labeling, and their
numbers increased with time. At fully functional synapses, AChR recycling was robust and comparable in
magnitude with the insertion of newly synthesized receptors, whereas chronic synaptic activity blockade
nearly abolished receptor recycling. Finally, using the same sequential labeling method, we found that
acetylcholinesterase, another synaptic component, does not recycle. These results identify an activity-
dependent AChR-recycling mechanism that enables the regulation of receptor density, which could lead to
rapid alterations in synaptic efficacy.
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Identification of Nicotinic Acetylcholine Receptor Recycling
and Its Role in Maintaining Receptor Density at the
Neuromuscular Junction In Vivo
Emile Bruneau,* David Sutter,* Richard I. Hume, and Mohammed Akaaboune
Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, Michigan 48109
In the CNS, receptor recycling is critical for synaptic plasticity; however, the recycling of receptors has never been observed at peripheral
synapses. Using a novel imaging technique, we show here that nicotinic acetylcholine receptors (AChRs) recycle into the postsynaptic
membrane of the neuromuscular junction. By sequentially labeling AChRs with biotin– bungarotoxin and streptavidin–fluorophore
conjugates, we were able to distinguish recycled, preexisting, and new receptor pools at synapses in living mice. Time-lapse imaging
revealed that recycled AChRs were incorporated into the synapse within hours of initial labeling, and their numbers increased with time.
At fully functional synapses, AChR recycling was robust and comparable in magnitude with the insertion of newly synthesized receptors,
whereas chronic synaptic activity blockade nearly abolished receptor recycling. Finally, using the same sequential labeling method, we
found that acetylcholinesterase, another synaptic component, does not recycle. These results identify an activity-dependent AChR-
recycling mechanism that enables the regulation of receptor density, which could lead to rapid alterations in synaptic efficacy.
Key words: toxin; turnover; synaptic transmission; neuromuscular junction; trafficking; acetylcholine receptor (AChR)
Introduction
The density of neurotransmitter receptors is an important pa-
rameter in regulating the efficacy of synaptic transmission. In
both the central (O’Brien et al., 1998; Carroll et al., 1999a) and
peripheral (Fambrough and Hartzell, 1972; Akaaboune et al.,
1999; Sanes and Lichtman, 2001) nervous systems, alterations in
synaptic transmission cause changes in postsynaptic receptor
density. Such changes are important in many forms of synaptic
plasticity, which lead to the strengthening or weakening of syn-
aptic connections (Carroll et al., 1999b; Luscher et al., 1999).
Several mechanisms at CNS synapses, including receptor recy-
cling, are known to be involved in regulating synaptic plasticity
(Nishimune et al., 1998; Noel et al., 1999; Ehlers, 2000; Kim and
Lisman, 2001; Malinow and Malenka, 2002; Bredt and Nicoll,
2003; Park et al., 2004). In peripheral cholinergic neuromuscular
junctions, however, it is not known whether acetylcholine recep-
tors (AChRs) are stable until they are removed and degraded in a
one-way trip to the lysosomes, or if they are in constant move-
ment between internal compartments and the plasma mem-
brane. To address this issue, we have developed a novel imaging
technique that enables us to study new aspects of AChR dynamics
at neuromuscular junctions in vivo. By selectively labeling differ-
ent AChR pools (preexisting, recycled, and new) within a single
synapse in the living mouse, we were able to provide an estimate
of the contribution of each pool to the neuromuscular junction
(NMJ) over time. We found that a significant number of these
receptors undergo recycling back to the NMJ, and this recycling is
dramatically affected by alterations in synaptic activity.
Materials and Methods
In vivo imaging. All animal usage followed methods approved by the
University of Michigan Committee on the Use and Care of Animals.
Adult female mice (20 –27 g, non-Swiss albino; Harlan Sprague Dawley,
Indianapolis, IN) were anesthetized with an intraperitoneal injection of
ketamine and xylazine (17.38 mg/ml). Sternomastoid muscle exposure
and neuromuscular junction imaging were done as previously described
in detail (Lichtman et al., 1987; van Mier and Lichtman, 1994;
Akaaboune et al., 1999). Briefly, the anesthetized mouse was placed on its
back on the stage of a customized epifluorescence microscope, and neu-
romuscular junctions were viewed under a coverslip with a water immer-
sion objective (20 UAPO, 0.7 numerical aperture; Olympus BW51;
Optical Analysis Corporation) and a digital CCD camera (EXi; Retiga,
Burnaby, British Columbia, Canada). Mice were intubated and venti-
lated for the duration of the imaging sessions. For imaging at multiple
time points, the mouse was sutured after each session and allowed to fully
recover before the next imaging session.
Labeling of distinct AChR pools. After exposure of the sternomastoid
muscle, AChRs were saturated first with fully substituted BTX– biotin (5
g/ml, 1.5 h; Invitrogen, Eugene, OR) and then with streptavidin conju-
gated to Alexa 660 (10 g/ml, 2.5 h; Invitrogen) to saturate all biotin sites.
To ensure that all receptors and all biotin sites were saturated, distinct
colors of tetramethyl-rhodaminated BTX conjugate (TMR–BTX) and
streptavidin–Alexa (streptavidin–Alexa 488) were added to the sterno-
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mastoid muscle. Superficial synapses were then immediately imaged un-
der the control of IPLAB software (Scanalytics). Hours or days later, the
mouse was reanesthetized, and the sternomastoid muscle was reexposed
and bathed with streptavidin–Alexa 488 to label the recycled AChRs and
TMR–BTX to label the new AChRs. The muscle was washed, and the
same synapses were relocated and imaged. In this way, we were able to
distinguish the preexisting, new, and recycled receptor pools. To rule out
the possibility that streptavidin–Alexa binds directly to receptors, ster-
nomastoid muscles were lightly labeled with TMR–BTX (5 g/ml, 2 min
application) to identify synapses. Streptavidin–Alexa 488 (green) (10
g/ml) was then applied to the sternomastoid muscle for 2.5 h. In these
junctions, no green labeling was observed, indicating that streptavidin
does not bind directly to receptors.
Denervation. The sternomastoid muscle was denervated by excising a 5
mm piece of nerve to prevent its regeneration. Ten days later, the mouse
was anesthetized and labeled as described above.
Muscle stimulation. Denervated muscle was stimulated by placing
stimulating electrodes at either end of the muscle (3 ms bipolar pulses of
10 –13 V at 10 Hz for 1 s duration every 2 s for the entire 8 h period).
Continuous blockade of activity. To study the effect of muscle postsyn-
aptic activity blockade on the insertion of recycled and new receptors,
curare (2.5 mg/ml), a poison that binds reversibly to AChRs, was applied
to the sternomastoid muscle to block neuromuscular transmission. For
the duration of the experiment, a coverslip was placed over the exposed
muscle to prevent it from drying. Every 2 h, additional curare solution
was applied to the muscle. Animals were intubated with a ventilator for
the duration of the experiment to prevent asphyxiation.
Cell culture. C2C12 cells (obtained from American Type Culture Col-
lection, Manassas, VA) were cultured on laminin-coated dishes in me-
dium containing 20% FBS and then switched after 2 d to 5% horse serum to
induce differentiation into myotubes. Three to 5 d after differentiation, cul-
tures were labeled and imaged as with muscles in vivo. We used the appear-
ance of the cells under phase contrast illumination to distinguish receptor
clusters on living muscle cells from ghost receptor clusters.
Immunocytochemistry. Longitudinal sections (20 m) of fixed [2%
paraformaldehyde (PFA)] sternomastoid muscle that was labeled 4 d
earlier with BTX– biotin (5 g/ml, 1.5 h) followed by a saturating dose of
fluorescent or unlabeled streptavidin (10 g/ml, 2.5 h) were blocked with
10% BSA and goat serum, permeabilized with 1% Triton X-100, and
incubated with primary antibodies for 1–2 h at room temperature in
blocking solution. The primary antibodies used were as follows: antibody
to biotin [1:200, monoclonal antibody (mAb) 2F5, anti-biotin–Alexa
488/594; Invitrogen]; rat anti-acetylcholine receptor (1:500, mAb35 or
mAb210; Sigma, St. Louis, MO); and rabbit anti-early endosomal antigen
(EEA1, 1:300; Abcam, Cambridge, MA). The sections were then washed
extensively in PBS and incubated for 1 h with secondary goat anti-rat
antibody conjugated to either Alexa 594 or Alexa 488 (Invitrogen) and/or
with secondary sheep anti-rabbit antibody conjugated to Texas Red
(Abcam).
Confocal microscopy. The analysis of intracellular and extracellular co-
localization was performed using a 60 oil-immersion lens and laser
illumination on a confocal Zeiss (Thornwood, NY) LSM 510 micro-
scope. A series of optical planes were collected in the z dimension (z-
stack) and collapsed into a single image. Images presented in Results were
produced and adjusted for brightness and contrast using Adobe (San
Jose, CA) Photoshop CS.
Quantitative fluorescence imaging. In experiments involving multiple
color fluorescent ligands (such as the one illustrated in Fig. 1), the camera
gain was adjusted to give a nicely exposed image on each color channel,
but because of differences in the extent of labeling of the different ligands
and the quantum efficiency of different fluorophores, it was not possible
to compare the relative number of molecules labeled with each ligand.
When such comparisons were essential (see Figs. 7, 8), the fluorescence
intensity of labeled receptors at neuromuscular junctions was assayed
using a quantitative fluorescence imaging technique, as described by
Turney et al. (1996) with minor modifications. This technique incorpo-
rates compensation for image variation that may be caused by spatial and
temporal changes in the light source and camera between imaging ses-
sions by calibrating all images with a nonfading reference standard. A key
feature of the quantitative imaging approach used in the current study is
that it involves three sequential labeling steps with the same ligands
(BTX– biotin and streptavidin–Alexa 594). Thus, as long as we verified
that labeling had reached saturation and that the image pixel intensity
was not saturated, it was simple to get an accurate quantitative measure-
ment corresponding to the number of AChRs in each pool.
Results
Recycling of AChRs at the neuromuscular junctions of
live animals
Experiments such as the one illustrated in Figure 1 suggested that
AChRs are recycled at the postsynaptic membrane of the neuro-
muscular junction. The sternomastoid muscle of this mouse was
labeled with a saturating dose of biotin-labeled -bungarotoxin
(BTX– biotin, 5 g/ml, 1.5 h), which binds with extremely high
affinity to AChRs (Green et al., 1975; Fambrough, 1979). BTX–
biotin-bound receptors were then saturated with streptavidin
conjugated to a fluorescent Alexa dye (10 g/ml, 2.5 h), which in
turn forms a noncovalent, very high-affinity bond with biotin
(Weber et al., 1989; Green, 1990). To test whether all receptors
were saturated with BTX– biotin and all biotins were saturated
with streptavidin–Alexa, immediately after the unbound BTX–
biotin and streptavidin–Alexa 660 were washed away (pseudo-
color, blue), the muscle was exposed to alternately colored
streptavidin–Alexa [streptavidin–Alexa 488 (green), 10 g/ml]
and fluorescent -BTX [TMR–BTX (red), 5 g/ml]. The super-
ficial synapses were then imaged (Fig. 1A). The absence of red
and green fluorescence indicates that saturation was achieved
(Fig. 1B,C). When the same synapse was exposed 24 h later to
streptavidin–Alexa 488 and TMR–BTX, much of the original flu-
orescence from the streptavidin–Alexa 660 remained (Fig. 1D),
but there was also significant fluorescence on the green (strepta-
vidin–Alexa 488) and red (-TMR–BTX) channels (Fig. 1E,F).
The blue label at 24 h indicates that most receptors were still
bound to both of the original ligands. The red label at 24 h indi-
cates those receptors that appeared on the surface after the initial
labeling period (whether newly synthesized or from an internal
storage pool) as well as any surface receptors that had lost their
BTX– biotin label. For the rest of this paper, all receptors that
stain with fluorescent -BTX after an initial saturating dose of
BTX will be referred to as part of the pool of “new” receptors. The
green fluorescence present at 24 h indicates receptors that re-
mained bound to BTX– biotin but that had lost their streptavidi-
n–Alexa 660 label. Given the expected high affinity of the strepta-
vidin– biotin bond, we were surprised by the extent of loss of
streptavidin. This matter is further considered below and in
Discussion.
Dissociation of streptavidin from the AChR– bungarotoxin–
biotin complex does not occur on the muscle surface
We performed a series of experiments to test whether the disso-
ciation of streptavidin from biotin–BTX–AChR could occur on
the cell surface. First, to estimate the intrinsic rate of dissociation
of streptavidin from the biotin–BTX–AChR complex at the neu-
romuscular junction, mice were perfused with 2– 4% parafor-
maldehyde in PBS, and the sternomastoid muscle was removed
and placed in a dish. We then labeled these muscles with saturat-
ing doses of BTX– biotin and then streptavidin–Alexa, as de-
scribed above. Three to 5 d later, the muscle was bathed with a
second color of fluorescent streptavidin. In contrast to the result
obtained for receptors at synapses in living animals at this time
(where a significant amount of the signal intensity was attribut-
able to receptors that had lost their original streptavidin–Alexa
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tag and were then able to be relabeled with new streptavidin–
Alexa at a later time point) (see Fig. 1), no fluorescence from the
second streptavidin fluorophore was observed. Thus, under these
conditions, the rate of biotin–streptavidin dissociation is negligi-
ble. Because both the BTX– biotin and the streptavidin–Alexa
were applied after fixation and extensive washing, this protocol
likely accurately reflects the extremely slow intrinsic rate of bi-
otin–streptavidin dissociation in the absence of processes associ-
ated with living cells.
Another possibility is that factors released from living muscle
may increase the dissociation of streptavidin on the muscle cell
surface. To test this possibility, we took advantage of “ghost”
clusters observed in aneural myotube cultures grown on laminin.
C2C12 myotubes grown on laminin display large, complex AChR
clusters that often remain bound to the laminin, even after the
muscle cell that used to hold them on its surface has died (Kum-
mer et al., 2004). Sequentially saturating these ghost clusters with
BTX– biotin and streptavidin–Alexa 594 therefore enabled the
analysis of AChR–BTX– biotin–streptavidin complexes isolated
from muscle membranes but still surrounded by living muscle
cells in a normal extracellular milieu.
When these ghost clusters were labeled
with either streptavidin–Alexa 488 or anti-
biotin 488 5 d later, no green fluorescence
was observed (Fig. 2A–C). Thus, there was
no detectable dissociation of streptavidin
over a 5 d period when receptors are sur-
rounded by medium but not on living
cells. We also tested for the dissociation of
streptavidin from BTX– biotin on the sur-
face of living myotubes. When receptor
clusters on the myotube surface were la-
beled with BTX– biotin and saturated with
streptavidin–Alexa 660 and then relabeled
12 h later with streptavidin–Alexa 488
(green) and BTX–Alexa 594 (Fig. 2D–G),
considerable red staining but no green
staining was observed. This indicated that,
despite a significant loss of fluorescence
(attributable to the turnover rate of AChR)
over this period and significant insertion
of new receptors, biotin–streptavidin dis-
sociation did not occur under these condi-
tions. We also found that there is no sig-
nificant difference in the rate of
internalization of receptors on cultured
C2C12 myotubes that were labeled with
either fluorescent bungarotoxin or BTX–
biotin–streptavidin–Alexa (supplemental
Fig. 1, available at www.jneurosci.org as
supplemental material). Together, these
results indicate that biotin–streptavidin
dissociation does not occur in the normal
extracellular environment, that recycling
does not occur in aneural myotubes, and
that streptavidin binding does not signifi-
cantly increase internalization.
Although the previous experiments
show that the dissociation of streptavidin
from biotin does not occur from the sur-
face of fixed muscle or AChR clusters on
living or dead cultured myotubes, it is still
possible that biological processes could oc-
cur at the surface of the NMJ of an intact muscle in vivo that might
cause streptavidin– biotin dissociation from the surface of syn-
apses (such as the secretion of proteases by infiltrating immune
cells). To examine this possibility, we transplanted a portion of a
sternomastoid muscle that was first fixed with 2% PFA and then
labeled with BTX– biotin–streptavidin–Alexa 594 into the neck of
a host mouse directly next to the living sternomastoid muscle. In
this way, the BTX– biotin–streptavidin bound to immobilized
receptors after fixation was exposed to a fully active and living
sternomastoid muscle environment. As in the previous in vivo
labeling studies described above, the mouse was then allowed to
recover. Seven days later, we quantified the amount of biotin–
streptavidin dissociation at the NMJs of the fixed and trans-
planted muscle. We found that the original fluorescence of the
transplanted muscles decreased by 3%, and we found no evi-
dence of new streptavidin–Alexa binding, compared with normal
levels of new streptavidin–Alexa binding observed at NMJs in the
live host muscle. These experiments indicate that extracellular
proteases do not cause biotin–streptavidin dissociation on the
surface of the muscle.
Figure 1. Multiple AChR pools are present at synapses on sternomastoid muscles of living mice. A, In a living adult mouse, a
neuromuscular junction of the sternomastoid muscle was labeled with a saturating dose of BTX– biotin followed by a saturating
dose of streptavidin (strept)–Alexa 660 (blue, pseudocolor). B, C, The junction was then immediately bathed with a saturating
dose of streptavidin–Alexa 488 (green) and TMR-BTX (red). The absence of any labeling (even when camera exposure was
increased significantly) indicates that all receptors and biotin sites were saturated by the initial applications. D–G, The same
neuromuscular junction imaged 24 h later, after application of new streptavidin–Alexa 488 (green) and TMR-BTX (red) to the
sternomastoid muscle. The remaining preexisting receptors were still labeled with BTX– biotin–streptavidin–Alexa 660 (blue,
pseudocolor). The streptavidin–Alexa 488 labeling indicates the presence of receptors that retained BTX– biotin sites but lost their
streptavidin–Alexa 660. These free sites are unlikely because of the loss of streptavidin on the surface (see Figs. 2–5) and therefore
referred to as recycled receptors. The TMR-BTX labeling indicates receptors that were not bound to either BTX– biotin or strepta-
vidin and are referred to as new receptors. Scale bar, 20 m.
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To further rule out the possibility of ex-
tracellular dissociation of streptavidin
from biotin, we used the same sequential
labeling protocol on another synaptic
component in vivo. Because of the avail-
ability of the snake toxin fasciculin 2,
which selectively and specifically labels
acetycholinestrase (AChE), we monitored
the dissociation of streptavidin from fasci-
culin 2– biotin over 4 d. AChEs were la-
beled with biotinylated fasciculin 2 (7 g/
ml, 1 h) and then saturated with
streptavidin–Alexa 594 (10 g/ml, 2.5 h).
The mouse was allowed to recover, and af-
ter 4 d, the sternomastoid muscle was ex-
posed to a new saturating dose of strepta-
vidin–Alexa 488 (green). In sharp contrast
to AChR recycling (Fig. 3A,B), we found
that AChEs originally labeled with fasci-
culin 2– biotin–streptavidin–Alexa 594
showed barely detectable green labeling
and therefore negligible biotin–streptavi-
din dissociation after 4 d (Fig. 3C,D).
These results show that the dissociation of
streptavidin from biotin does not occur on
the surface of the synapses and rules out
the possibility that extracellular proteases
or other unknown cellular processes at the
cell surface are responsible for such disso-
ciation, suggesting that this dissociation
likely occurs in intracellular compart-
ments after being internalized.
In denervated muscle, receptors are
known to turn over at an accelerated rate,
and muscle stimulation has been shown to
prevent this increase in receptor loss (Sal-
peter and Loring, 1985; Andreose et al.,
1993; Caroni et al., 1993; Akaaboune et al.,
1999). If dissociation does not occur on
the surface but only after the AChR–BTX–
biotin- streptavidin complex is internal-
ized, one would predict that decreasing
the rate of internalization of receptors
would also decrease the streptavidin– bi-
otin dissociation. To test this possibility,
we labeled synaptic AChRs on denervated muscle with BTX–
biotin followed by streptavidin and then directly stimulated
the sternomastoid muscle by placing stimulating electrodes at
either end of the muscle for the entire 8 h experiment. As
predicted from the previous results of others, 8 h after stimu-
lation, we found no evidence of receptor loss (supplemental
Fig. 2 A, available at www.jneurosci.org as supplemental ma-
terial). Furthermore, when we added a second dose of strepta-
vidin–Alexa and then quantified the recovery of fluorescence,
we did not see any evidence for new streptavidin–Alexa bind-
ing. In contrast, a loss of preexisting fluorescence and the
binding of new streptavidin–Alexa were easily measured in
control, unstimulated muscle over the same time window
(supplemental Fig. 2 B, available at www.jneurosci.org as sup-
plemental material). This result argues strongly that the dis-
sociation of streptavidin from AChR–BTX– biotin does not
occur spontaneously on the muscle surface but, rather, only
after internalization.
Evidence for the intracellular dissociation of streptavidin
from the AChR– bungarotoxin– biotin complex
If streptavidin dissociates from the AChR–BTX– biotin-Strepta-
vidin–Alexa complex at an intracellular site, it should be possible
to observe Alexa fluorescence in intracellular vesicles. It should
also be possible to observe intracellular vesicles with biotin freed
from streptavidin. To test the first possibility, muscles were ini-
tially labeled with a saturating dose of BTX– biotin (5 g/ml,
1.5 h) followed by a saturating dose of fluorescent streptavidin–
Alexa 488. After an appropriate waiting time (4 d), the mouse was
perfused with 2% paraformaldehyde. The sternomastoid muscle
was then dissected and cut in longitudinal sections parallel to the
axis of the muscle fibers to allow visualization of both the cell
surface and the region below it, using confocal microscopy.
In control muscles that were labeled with BTX– biotin–
streptavidin–Alexa 488 and then immediately fixed and sec-
tioned (rather than waiting 4 d), the antibody-mediated AChR
labeling was intense at the surface receptors of the synapse, plus a
Figure 2. Streptavidin does not dissociate from AChR–BTX– biotin clusters on muscle cells in culture. A, In C2C12 myotube
cultures, ghost clusters (as described by Kummer et al., 2004) that were no longer associated with myotubes were labeled with
BTX– biotin followed by streptavidin–Alexa 594. B, Five days later, the same clusters were treated with streptavidin–Alexa 488
(to identify receptors that retained BTX– biotin and lost streptavidin). C, Overlay of images in A and B. The absence of green
labeling in B indicates that there was no dissociation of streptavidin from receptor– bungarotoxin– biotin complexes on ghost
clusters after 5 d. D, AChRs on a living C2C12 myotube that were labeled with a saturating dose of BTX– biotin followed immedi-
ately by a saturating dose of streptavidin–Alexa 660 (pseudocolor blue) and then imaged 12 h later. E, F, The same cells were then
incubated with streptavidin–Alexa 488 (green) to label receptors that retain BTX– biotin and lose streptavidin and BTX-Alexa 594
(red) to label new AChRs. The absence of green labeling in E indicates that no detectable streptavidin– biotin dissociation occurred
over this period, whereas the red labeling indicates the addition of new receptors. G, Overlay of D–F. Scale bars, 20 m.
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number of small spots (puncta), whereas the streptavidin–Alexa
labeling was also intense on the cell surface but not visible in
puncta. This is the expected result because the AChR immuno-
cytochemistry detects all receptors, including those present inter-
nally, whereas the streptavidin–Alexa staining procedure initially
detects only surface receptors, and some time must elapse before
they become internalized. However, when 4 d were allowed be-
tween labeling and fixation, we found that most of the initial
streptavidin label colocalized with receptors on the surface and in
intracellular puncta (Fig. 4A–F); z-stack analysis of the images
confirmed that these colocalized fluorescent spots were beneath
the muscle surface, indicating that AChR–BTX– biotin–strepta-
vidin was internalized as a complex. A significant number of the
intracellular AChR-containing puncta were also labeled only by
the anti-receptor antibody. These could be receptors that have
lost their streptavidin label and are either in the process of recy-
cling or degradation or unlabeled newly synthesized receptors yet
to be inserted. A small number of green fluorescent spots were
also observed, which did not colocalize with receptors, perhaps
corresponding to accumulation of fluorescence in degradative
vesicles.
It seemed likely that many of the puncta were intracellular
vesicles. To test this possibility, muscle fibers were fixed and then
processed so that AChR and the early endosome marker EEA1
could be detected immunocytochemically (Fig. 4G–O). The
EEA1 labeling was present in a profusion of small spots located
below the cell surface, whereas the AChR labeling consisted of
intense labeling of the surface receptors of the synapse plus a
modest number of small spots. Although many EEA1 spots were
negative for AChR, most AChR-positive spots were also positive
for EEA1. Thus, puncta of AChR staining represent reliable
markers of internalized AChR. Given the high correlation be-
tween AChR labeling of puncta and EEA1 labeling of puncta, the
presence of puncta that were labeled both for AChR and for
streptavidin in the experiments shown in Figure 4A–F demon-
strates that fluorescent Alexa from surface AChRs labeled with
BTX— biotin–streptavidin–Alexa is internalized. The puncta
that stained only with the antireceptor antibody but were nega-
tive for Alexa most likely represent newly synthesized receptors
yet to be inserted, whereas the puncta that stained for Alexa but
not for AChR seem likely to correspond to degradative vesicles
that have completely consumed their AChR.
Having shown that the Alexa from AChR–BTX– biotin–
streptavidin–Alexa complexes can be internalized, we next tested
whether biotin that had lost streptavidin could also be observed
inside of muscle fibers. We first showed that the anti-biotin an-
tibody we were using can effectively stain AChR–BTX– biotin
complexes (Fig. 5A) but not AChR–BTX– biotin–streptavidin–
Alexa 488 complexes (Fig. 5B–D). Thus, if muscles are pretreated
with BTX– biotin and streptavidin–Alexa, this antibody will label
only receptor complexes that have been stripped of streptavidin.
Confocal images of muscle sections saturated with BTX– biotin–
streptavidin and fixed and processed 4 d later showed that stain-
ing with both the anti-AChR antibody and the anti-biotin anti-
body labeled the entire synaptic region, and both fluorescent
labels were also found colocalized in small spots in the vicinity of
the junction (Fig. 5E–J). Approximately 40% of the intracellular
spots were labeled by both antibodies, and the rest were labeled
only by the antireceptor antibody. An alternate approach was also
used to confirm the presence of free biotin within puncta. Lon-
gitudinal sections of mouse sternomastoid muscle saturated 4 d
previously with BTX– biotin followed with streptavidin–Alexa
594 or unlabeled streptavidin were fixed and permeabilized as
described above and labeled with the antireceptor antibody and
streptavidin–Alexa 488. The number of green fluorescent puncta
was similar to the number obtained when the anti-biotin anti-
body was used.
In summary, we see AChR–BTX– biotin complexes that have
been stripped of their streptavidin labels both in intracellular
vesicles and on the cell surface in vivo. Because we have seen no
indication that dissociation occurs on the cell surface, the likely
sequence is that the AChR–BTX– biotin–streptavidin complex is
endocytosed into vesicles; the streptavidin is stripped off the
complex and degraded; and then the AChR–BTX– biotin com-
plex is returned to the surface. For these and other reasons con-
sidered in Discussion, we will refer to the pool of receptors that
Figure 3. Lack of streptavidin (Strept) dissociation from AChE–fasciculin 2– biotin in vivo. A,
Example of a living adult mouse neuromuscular junction previously labeled with BTX– biotin (to
label AChRs) followed by a saturating dose of streptavidin–Alexa 594 (red) at time 0 and im-
aged at 4 d. Red signal indicates the preexisting receptors still remaining on day 4. B, Same
neuromuscular junction imaged after application of streptavidin–Alexa 488 (green). Green
signal indicates the AChRs that were recycled over 4 d. C, Example of an NMJ labeled with
fasciculin 2-biotin (to label AChEs) followed by a saturating dose of streptavidin–Alexa 594
(red) at time 0 and imaged at 4 d. Red signal indicates the preexisting acetycholinestrase
remaining on day 4. D, The same neuromuscular junction imaged after application of new
streptavidin–Alexa 488 (green) and viewed with much higher camera gain than used in B. The
weak green signal indicates that there is very little streptavidin dissociation after 4 d. When the
same gain was used as in B, the fluorescence was almost undetectable. Scale bars, 20 m.
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can be relabeled with a second color of streptavidin–Alexa as
“recycled receptors.”
Time-lapse imaging of synaptic AChR recycling
Having found that receptors are able to recycle, we next wanted to
determine how quickly recycled receptors were incorporated into
the postsynaptic membrane. To do this, sternomastoid muscles
were labeled with a low dose of BTX– biotin (5 g/ml, 2 min, to
ensure that synaptic activity remained fully functional) (Lingle
and Steinbach, 1988) followed by a saturating dose of streptavidi-
n–Alexa 488. A dose of streptavidin–Alexa 594 (30 min) was then
added to ensure the saturation of all biotin sites (Fig. 6A,B). Every
2 h, a fresh dose of streptavidin–Alex 594 was added to the muscle
to label recycled receptors. Using high detector gain with a CCD
camera, we were able to see a clear red fluorescence signal at 2 h.
In all 10 synapses imaged in three mice, the fluorescence signal
increased in intensity after each new streptavidin–Alexa 594 ap-
plication (Fig. 6C–F). This result suggests that recycled receptors
are rapidly inserted into the membrane.
Effect of synaptic activity on the recycled and new
AChR pools
To quantitate the number of recycled and new receptors inserted
into the same synapse over time, we used the same fluorophore in
three distinct labeling steps, which allowed us to distinguish each
receptor pool, and then we assayed fluorescence intensity using
an established in vivo quantitative fluorescence method (Turney
et al., 1996; Akaaboune et al., 1999). The sternomastoid muscles
of six mice were saturated with an initial dose of BTX– biotin (5
g/ml, 1.5 h) followed by streptavidin–Alexa 594 (red) (10 g/
ml, 2.5 h) to saturate biotin sites. The fluorescence intensity of
superficial neuromuscular junctions was then assayed at time 0
and then at a second time point 8 h or 1, 3, or 4 d later (Fig. 7A,B).
At 4 d, we found that junctions labeled at time 0 with a saturating
dose of BTX– biotin–streptavidin–Alexa 594 had lost 53  3%
(SD; n  30) of their original fluorescence. To quantitate the
amount of receptors that were recycled over time, we applied a
second saturating dose of streptavidin–Alexa 594 and measured
the resulting increase in fluorescence intensity. We found that at
4 d, the fluorescence from the recycled receptors equaled 26 
5% (SD; n  29) of the original fluorescence (Fig. 7A,B).
To quantitate the contribution of the new receptors added to
these same synapses during the 4 d, the sternomastoid muscle was
then labeled with a fresh saturating dose of BTX– biotin followed
with a fresh saturating dose of streptavidin–Alexa 594. We found
that an additional 24  5% (SD; n  29) of the original fluores-
cence was recovered (Fig. 7A,B). In summary, 4 d after a single
transient application of BTX– biotin, the sum of remaining orig-
inal (preexisting), new, and recycled receptors was very close to
100% of the original signal, and the contributions of newly in-
4
indicate intracellular puncta that contained only receptors (likely unlabeled receptors that are in
the process of insertion or BTX– biotin-labeled receptors in the process of recycling). Green
arrowheads indicate intracellular puncta that contained only streptavidin–Alexa 488. G–O,
Example of a neuromuscular junction on a muscle section (labeled as described above) immu-
nostained for AChRs and EEA1. G–I, Eight confocal slices at 2 m intervals were collapsed onto
a single image plane. In the overlay image, green indicates anti-AChR immunostaining, and red
indicates anti-EEA1 immunostaining. J–L, The boxed regions of G–I shown at higher power.
M–O, z-stack of fluorescence intensity taken at various depths along the white lines in J–L. The
top of the section is to the right, and the width of these panels corresponds to a total depth of 20
m.
Figure 4. Confocal imaging of AChR– bungarotoxin– biotin–streptavidin (Strept) com-
plexes in intracellular compartments. Sternomastoid muscles were labeled in living mice with
BTX– biotin and saturated with streptavidin–Alexa 488. After 4 d, the muscles were fixed,
sectioned longitudinally, and then processed for immunocytochemical detection of AChRs with
an Alexa 594-conjugated secondary antibody. A, Example of a stack of 20 confocal images (0.5
m intervals) of an NMJ that was initially labeled with BTX– biotin–streptavidin–Alexa 488
and collapsed onto a single plane. The small green fluorescence puncta could represent either
the accumulation of fluorescent streptavidin still attached to AChR–BTX– biotin complexes or
the accumulation of fluorescent streptavidin in intracellular compartments. B, Immunostaining
with anti-AChR and secondary antibody conjugated to Alexa 594. These puncta could represent
the presence of receptors that are newly synthesized, internalized and recycling, or internalized
and in the process of degradation. C, Overlay of the Alexa 488 fluorescence in green and the
anti-AChR fluorescence in red. D–F, Detail from the boxed regions in A–C. Arrows indicate
colocalization of original streptavidin–Alexa 488 (green) and AChR (red) in intracellular puncta,
showing that the AChR-BTX– biotin–streptavidin complexes are internalized. Red arrowheads
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serted receptors and recycled receptors were nearly equal at
25% of original fluorescence each.
When the contributions of original, recycled, and new recep-
tors were examined at earlier time points after the initial labeling
(Fig. 7B), several interesting characteristics became apparent. At
1 d after a one-time bungarotoxin–AChR blockade, the contri-
bution of recycled receptors was less [18 
5% (SD) of original fluorescence recov-
ered; n  25] than that of new receptors
[22  5% (SD) of original fluorescence re-
covered; n  20; p  0.005]. This effect
was even more pronounced at 8 h with re-
cycled receptors contributing 9  3% (SD)
of original fluorescence (n  30) and new
receptors accounting for 17  7% (SD;
n  20; p  0.0001) (Fig. 7B).
Receptors in the pools defined as pre-
existing and recycled both have BTX
bound and so do not function, but the re-
ceptors in the new pool are unlabeled and
therefore unblocked and functional. In the
NMJ, it is known that a large safety factor
exists that enables synapses to be fully
functional with only 10 –20% of receptors
being unblocked (Lingle and Steinbach,
1988). Therefore, it would be expected
that by 8 h, the 17% of the total receptors
that are new and unblocked would be suf-
ficient to restore superthreshold end plate
potentials and muscle-spiking activity. It
thus seemed likely that the changes in the
rate of receptor recycling in transiently
blocked NMJs (1.5 h one-time bungaro-
toxin treatment) are the consequence of
the initial activity blockade by BTX and
subsequent restoration of neuromuscular
transmission by new unlabeled and un-
blocked AChRs.
To further examine the role of synaptic
activity on the insertion of recycled and
new receptors, we monitored the appear-
ance of receptors in continuously blocked
synapses, in which AChRs are reported to
be lost at an accelerated rate (Salpeter and
Loring, 1985; Martyn et al., 1992;
Akaaboune et al., 1999). To test the effect
of activity cessation on receptor traffick-
ing, we chronically blocked synaptic trans-
mission with curare (a poison that revers-
ibly blocks AChRs) and so indirectly
blocked muscle spiking. The longest this
treatment could be performed without
mortality was 8 h plus a 2 h treatment to
label either recycled receptors or new re-
ceptors but not both. However, this was
sufficiently long to resolve several interest-
ing differences from the one-time labeling
of AChRs with saturating bungarotoxin, in
which blockade is transient and muscle ac-
tivity recovers over time (Fig. 8). First, as
expected from previous studies, the re-
moval of original receptors was more pro-
nounced (on average falling to 65% of the
initial fluorescence at 8 h compared with 74% in animals receiv-
ing a one-time block with BTX). Second, the rate of appearance of
new AChRs decreased to approximately one-third that observed
when synaptic transmission was restored after a few hours but
remained at observable levels [4.5  2% (SD); n  20]. Most
dramatically, the contribution of the recycled receptors decreased
Figure 5. Confocal images of AChR-BTX– biotin complexes in intracellular compartments. A, Example of a neuromuscular
junction labeled with BTX– biotin followed by anti-biotin–Alexa 488 or 594. This staining was a positive control to demonstrate
that this antibody is able to effectively label biotin in complex with AChR. B, Example of a neuromuscular junction that was labeled
with biotin-bungarotoxin followed by a saturating dose of streptavidin (strept)–Alexa 488 and then immediately fixed. C, When
the same synapse was immunostained with anti-biotin–Alexa 594, no red fluorescence was observed. The absence of staining
with anti-biotin indicates that this antibody can only interact with BTX– biotin when it has been stripped of streptavidin. D,
Overlay of images in B and C. E, Example of a synapse on a muscle initially incubated with BTX– biotin–streptavidin and then fixed
and sectioned 4 d later and immunostained with anti-AChR and an Alexa 594-conjugated secondary antibody. F, Same synapse as
in E labeled with anti-biotin–Alexa 488. G, Overlay of images in E and F. H–J, Boxed areas from E–G at higher magnification and
viewed at a camera gain sufficient to saturate the signal from synaptic AChRs to accentuate the signal coming from the internal
spots. Arrowheads indicate spots of fluorescence that stained positive for AChR, but not for biotin, and arrows indicate spots where
both labels were colocalized. Scale bar, 20 m.
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to nearly undetectable levels [0.4  1% (SD) of original fluores-
cence; n  60] (Fig. 8A,B).
Discussion
These results are based on the surprising finding that at sterno-
mastoid muscle synapses in living mice, streptavidin dissociates
unexpectedly rapidly from AChR–BTX– biotin complexes. The
dissociation of purified streptavidin from biotin in test tube as-
says is extremely slow because of their extraordinarily high affin-
ity (Chilkoti and Stayton, 1995). It therefore was a great surprise
to us that at sternomastoid muscle synapses in living mice,
streptavidin-binding sites rapidly appeared on the surface of
muscle fibers after initial saturation with biotin–BTX followed by
saturation with streptavidin–Alexa. One possible explanation
was that biotin–BTX was able to label AChR inside the muscle
fibers as well as on the muscle cell surface, but the streptavidin–
Alexa could only bind to receptors on the cell surface of living
muscle fibers. Were this the case, the appearance of new
streptavidin-binding sites over time would represent the delivery
of preexisting intracellular biotin–BTX–AChR complexes to the
surface, rather than the creation of such complexes as a conse-
quence of dissociation of the streptavidin from the biotin. Two
lines of evidence rule out this possibility. First, according to this
hypothesis, the rate of appearance of new streptavidin-binding
sites after saturation with biotin–BTX and Alexa–streptavidin
should have been much greater on C2C12 myotubes than on
muscle fibers in living mice because cultured cells are known to
have a much larger pool of intracellular AChRs (Devreotes and
Fambrough, 1975), and these cultured myotubes rapidly inter-
nalize existing surface receptors and deliver new ones to the sur-
face (Fig. 2, supplemental Fig. 1, available at www.jneurosci.org
as supplemental material). However, there was no detectable ap-
pearance of new streptavidin-binding sites on the cell surface of
C2C12 myotubes (Fig. 2). Second, the results of experiments pre-
sented in Figure 5 demonstrated that biotin–BTX applied to the
surface of muscle fibers in living mice did not have access to
intracellular AChR. In this series of experiments, free biotin was
detected with an anti-biotin antibody in fixed, sectioned muscle
fibers that were treated before fixation with saturating levels of
biotin–BTX and then streptavidin-Alexa. The absence of any de-
tectable free biotin in muscles fixed shortly after labeling (Fig. 5C)
demonstrated that there was no intracellular AChR pool labeled
only with biotin–BTX. We conclude from these results that
streptavidin must be dissociating unexpectedly rapidly from
AChR–BTX– biotin complexes.
Our observation that biotin–streptavidin dissociation occurs
at an accelerated rate in vivo is not unprecedented: avidin– biotin
complexes have been previously reported to dissociate after their
intraperitoneal injection into live animals (Fraenkel-Conrat and
Fraenkel-Conrat, 1952; Wei et al., 1971; Lee et al., 1972, 1973a,b).
One potential molecular mechanism for enhanced dissociation
comes from an older study that reported that, although the avi-
din– biotin complex is highly resistant to elevated temperature,
acidic or basic pH, and proteases, the weak oxidizing environ-
ment provided by 0.3% H2O2 can readily cause dissociation (Gy-
orgy, 1943), which could allow the specific liberation of the
streptavidin–Alexa tag from the AChR–BTX– biotin complex
without affecting the AChR–BTX bond. A second potential
mechanism for enhancing unbinding is suggested by recent stud-
ies conducted on purified proteins. When added to biotin–
streptavidin complexes, two different classes of proteins have
been demonstrated to have the ability to rapidly displace the
streptavidin from the biotin (Subramanian et al., 1997; Morris
and Raney, 1999). In both cases, the extra protein (a helicase in
one study and a monoclonal antibody in the other) can be
thought of as a chaperone, placing the streptavidin in a non-
native conformation that enhances unbinding. It seems plausible
that the combination of low pH, an oxidizing environment, and
perhaps some modification in the conformation of streptavidin
by unknown factors within recycling vesicles could be responsi-
ble for the observed dissociation of streptavidin–Alexa from bi-
otin. This mechanism would also be consistent with the absence
of dissociation on the cell surface because this is a relatively re-
ducing environment at nearly neutral pH.
The cellular location of dissociation of streptavidin
from biotin
For several reasons, we believe that the dissociation of streptavi-
din from biotin takes place within intracellular vesicles rather
than on the cell surface. First, we saw no evidence for strepta-
vidin– biotin dissociation occurring on the cell surface of fixed
muscle tissue (even when transplanted into an in vivo milieu),
from AChR ghost clusters or from clusters of AChRs on living
aneural muscle cells in culture. Second, we could readily observe
AChR–BTX– biotin complexes that had been stripped of strepta-
vidin in intracellular vesicles near synaptic sites in sternomastoid
muscles. Third, when the rate of internalization of receptors was
greatly decreased by electrical stimulation of the muscle, we could
Figure 6. Time-lapse imaging of the appearance of recycled receptors. A, In a living adult
mouse, a neuromuscular junction of the sternomastoid muscle was labeled with a low dose of
BTX– biotin followed by a saturating dose of streptavidin (strept)–Alexa 488 (green). B, The
junction was then immediately bathed with a saturating dose of streptavidin–Alexa 594 (red)
and viewed at substantially higher gain. The absence of any red labeling indicates that all
biotins were initially saturated with streptavidin–Alexa 488. C–F, The same neuromuscular
junction imaged every 2 h for 8 h after application of new streptavidin–Alexa 594 (red) to the
sternomastoid muscle before each time point. Scale bar, 20 m. Similar results were obtained
at 10 synapses from three mice.
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no longer detect dissociation of streptavidin from biotin. Finally,
when the same labeling protocol was applied to AChE, a compo-
nent of the synaptic cleft localized in the extracellular matrix
rather in the plasma membrane, there was no evidence of strepta-
vidin– biotin dissociation. This last observation implies that
AChE is recycled very slowly or not at all. Insertion of AChE into
the basal lamina requires collagen (ColQ) (Feng et al., 1999), so
one possible explanation for the failure to recycle is that AChE–
fasciculin 2– biotin–streptavidin complexes are internalized after
detaching from ColQ and are therefore unable to insert back into
the basal lamina. Whatever the reason for the lack of streptavidin
unbinding from AChE complexes over time, these findings pro-
vide compelling evidence that local surface events are not respon-
sible for the biotin–streptavidin dissociation observed with
AChRs at the living neuromuscular synapse.
A final reason for favoring vesicles as the site of the biotin–
streptavidin dissociation is that a vesicular intermediate provides
a ready explanation for the observation
that the ability to recycle receptors to the
cell surface can be dissociated from the
ability to endocytose. Under two situa-
tions in which there was no synaptic activ-
ity (aneural cultures of C2C12 myotubes
and in vivo synapses chronically blocked
with curare), internalization of receptors
was readily detected, as expected from pre-
vious results (St. John and Gordon, 2001),
yet we saw no indication that there was any
recycling (no vacant streptavidin binding
sites on the cell surface). Regarding the
failure to observe receptor recycling in cul-
tured C2C12 myotubes, it has been shown
previously that a large subsurface “hid-
den” pool of receptors exists in cultured
chick and rat myotubes, but such a pool is
absent in innervated muscle (Devreotes
and Fambrough, 1975). This pool consti-
tutes up to 30% of the total AChR comple-
ment of cultured myotubes and was found
to derive partially from the surface of the
muscle as opposed to newly synthesized
receptors (Devreotes and Fambrough,
1975). As with AChRs at inactive synapses
in living mice, these cultured muscle fibers
are apparently lacking a signal that allows
the internalized receptors to return to the
cell surface.
Both the in vitro and in vivo results
could be readily explained if vesicles con-
taining receptors available for recycling
are delivered to the cell surface only when
there is synaptic activity. An obvious can-
didate for mediating the activity-
dependent signal is intracellular calcium
because it is the most common signal that
regulates exocytosis in both secretory and
nonsecretory cells (Chavez et al., 1996). At
CNS synapses, Ca 2 influx into the
postsynaptic cell through NMDA recep-
tors is involved in AMPA receptor recy-
cling in cortical and hippocampal neurons
(Carroll et al., 1999b; Luscher et al., 1999).
Such alterations in AMPA and NMDA re-
ceptor numbers in the postsynaptic density are proposed to ac-
count for changes in synaptic strength (Malinow and Malenka,
2002; Malinow, 2003). Indeed, the activity-dependent cycling of
AMPA receptors at the postsynaptic membrane underlies many
aspects of synaptic plasticity (Malinow and Malenka, 2002; Ma-
linow, 2003; Park et al., 2004). At the NMJ, AChRs allow the entry
of calcium in addition to sodium and potassium, so it is conceiv-
able that blocking the receptors could inhibit Ca 2 influx and
thus block a signal required for receptor recycling.
What is the extent of AChR recycling at normally
functioning synapses?
Our experiments have demonstrated that AChR recycling can
occur at the neuromuscular junction of living mice. Although
measurements of changes in fluorescence intensity over time
were made with great precision, there are several important ca-
veats to the interpretation of our results that cause us to be cau-
Figure 7. Quantification of original, recycled, and new receptors at the neuromuscular junction after transient activity block-
ade. These pseudocolor images provide a linear representation of the density of AChRs (white–yellow, high density; red– black,
low density). A, Example of a mouse neuromuscular junction labeled with a saturating dose of BTX (btx)– biotin followed imme-
diately by a saturating dose of streptavidin (strep)–Alexa 594, imaged, and then reimaged 4 d later. The total fluorescence
intensity (a measure of the total number of AChRs) was expressed as 100% at the initial labeling (left panel, day 0) and normalized
to this on each successive view. Second panel from left, Preexisting receptors remaining after 4 d when 50% of the initial
fluorescence is lost. To quantitate the recycled receptors, streptavidin–Alexa 594 (red) fluorophore was then added to the muscle.
Third panel from left, Sum of preexisting and recycled receptors after 4 d. New receptors were identified by next adding a
saturating concentration of BTX– biotin followed by a saturating dose of streptavidin–Alexa 594 (red), as shown in the fourth
panel. synth., Synthesized receptors. The fluorescence from these new receptors is added to the preexisting and recycled receptors
to determine the total receptor density after 4 d. B, Summary of the amount of original receptors remaining after various times and
the proportion of new and recycled receptors that were inserted into the synapse, obtained from many junctions with the
approach shown in A. Each data point represents the mean percentage of original fluorescence intensity  SEM (error bars).
Figure 8. Quantification of original, recycled, and new receptors at the neuromuscular junction after a transient and main-
tained activity blockade. A, Assessment of the extent of recycling 8 h after an initial transient blockade of activity with BTX– biotin.
B, Assessment of the extent of recycling 8 h after a maintained blockade of activity with curare. C, Summary of results obtained
from many synapses studied as in A and B. The data show the mean  SEM (error bars). For all four conditions, the difference
between the two experimental groups was significant ( p  0.001). These experiments were not performed beyond 8 h because
of mouse mortality from the long-term curare treatment. It thus was not possible to measure recycling and new receptors at the
same synapses. The insertion of new receptors was therefore measured in a parallel experiment using BTX–Alexa 594. strept,
Streptavidin.
Bruneau et al. • AchR Recycling In Vivo J. Neurosci., October 26, 2005 • 25(43):9949 –9959 • 9957
tious about extrapolating these data to estimate the rates of inter-
nalization and recycling of native receptors when activity is
unmodified.
First, only receptors that have been internalized have the pos-
sibility of recycling. If the internalization rate is slow, it is more
difficult to detect recycling, even if the cellular mechanisms that
cause recycling are fully functional.
Second, it is necessary to bind the bulky ligands -BTX– bi-
otin and streptavidin–Alexa to detect recycling. It is unclear to
what extent the binding of streptavidin alters the life history of
receptors. For instance, it is widely accepted that antibody bind-
ing to AChR can accelerate the rate of internalization and degra-
dation (Fumagalli et al., 1982), perhaps as a consequence of cross-
linking or because of other unknown factors. Streptavidin has
four biotin-binding sites and so has the potential to cross-link
biotins on multiple toxin molecules and thus indirectly cross-link
receptors. However, the time course of the loss of fluorescence on
cultured myotubes was not significantly different when receptors
were directly labeled with -BTX–Alexa or indirectly labeled with
-BTX– biotin and then with streptavidin–Alexa. This indicates
that either steric factors prevented the streptavidin from cross-
linking receptors labeled with biotin–BTX, or receptors cross-
linked by streptavidin do not have an altered rate of internaliza-
tion beyond any effect of -BTX alone. It should be emphasized
that recycling was readily detected at 8 h, but little or no detect-
able recycling occurred over the same period under three other
experimental conditions (receptor clusters on cultured myo-
tubes, synapses chronically inhibited with curare, and synapses
on denervated muscle fibers that were chronically stimulated).
Thus, binding of streptavidin to biotin–BTX is not sufficient to
trigger recycling. Furthermore, at the stage that receptors recycle,
they are no longer bound to streptavidin–Alexa, so the streptavi-
din is not necessary for the process to occur.
Finally, the amount of recycling we detect is a minimum esti-
mate, and the actual amount could be greater. There are two
possible ways that receptors could recycle without being detected
by the methods we used. Any receptor that is endocytosed and
returned to the cell surface without losing either its -BTX– bi-
otin or its streptavidin–Alexa will be counted as part of the pre-
existing pool, even though it has recycled. Similarly, any receptor
that loses its -BTX– biotin and then recycles will be counted as
part of the new pool. At present, there are no available methods
that would allow us to determine whether either of these two
types of events occurs at a sufficient frequency to significantly
increase the actual recycling rate above what we measured. Even
without including any contribution from these potential sources
of additional recycled receptors, we have demonstrated that, un-
der one specific condition (recovery from a one-time blockade
with BTX), at least 9% of the synaptic receptors on the cell surface
were recycled over the first 8 h period, and 25% of the surface
receptors were recycled over a 4 d period.
The existence of a recycled pool of AChRs requires that a
number of earlier experiments on the life history of AChRs be
reinterpreted. For instance, a substantial number of experiments
using fluorescently labeled -BTX have shown that the half-life of
fluorescence loss at synapses in living mice is 7 d after a one-
time blockade with bungarotoxin (Salpeter and Loring, 1985;
Andreose et al., 1993; Caroni et al., 1993; Akaaboune et al., 1999,
2002). This had been interpreted as the half-life of receptors on
the cell surface, but our results suggest that each receptor can
recycle back to the cell surface (perhaps several times) before it is
degraded, and junctional AChRs are therefore being internalized
from the surface at a significantly faster rate than previously
thought. The results reported here suggest that, despite the sta-
bility of the synaptic structure over the lifetime of the animal
(Balice-Gordon and Lichtman, 1990), receptors are highly dy-
namic and are constantly exchanged between the plasmalemma
and internal compartments, in addition to being frequently shut-
tled between junctional and extrajunctional regions (Akaaboune
et al., 2002).
Together, our results suggest a model for the regulation of the
postsynaptic receptor density at the neuromuscular junction in
live animals involving two separate pathways: a receptor-
recycling pathway and a new receptor pathway. When postsyn-
aptic transmission is functional, both the recycled and the new
receptor pathways contribute significantly to the postsynaptic
density (supplemental Fig. 3A, available at www.jneurosci.org as
supplemental material). In the absence of postsynaptic activity,
however, internalized AChRs are shifted from a recycling path-
way to a degradative pathway (supplemental Fig. 3B, available at
www.jneurosci.org as supplemental material). The new receptor
insertion pathway is also affected by the absence of postsynaptic
activity but continues to deliver receptors at a reduced rate. We
do not know, however, whether new and recycled receptors are
added directly to the junction or are inserted into the perijunc-
tional region and then migrate into the junction to be anchored.
It would be of considerable interest to see whether different pat-
terns of activity can alter the proportion of new and recycled
receptors at synapses in live animals.
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